Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells

Annals of the New York Academy of Sciences

Volumn 992, Issue , 2003, Pages 196-204

  Refojo, Damián ^a   Liberman, Ana C ^a   Giacomini, Damiana ^a   Nagashima, Alberto Carbia ^a   Graciarena, Mariana ^a   Echenique, Carlos ^a   Paez Pereda, Marcelo ^b   Stalla, Günter ^b   Holsboer, Florian ^b   Arzt, Eduardo ^a,c  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apoptosis; BMP 4; cAMP; Estrogen; GATA 3; Glucocorticoid; Prolactinoma; T cell receptor (TCR); T bet; Th1 Th2 differentiation; Tumor necrosis factor (TNF)

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; SMAD4 PROTEIN; STEROID HORMONE; STEROID RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR;

ADAPTATION; APOPTOSIS; CARCINOGENESIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOTOXICITY; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; PROLACTINOMA; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TARGET CELL; TH1 CELL; TH2 CELL; TRANSACTIVATION;

EID: 0038468332     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03150.x     Document Type: Conference Paper

References (27)

1. SCHÖBITZ, B., E.R. DE KLOET & F. HOLSBOER. 1994. Gene expression and function of interleukin 1, interlukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44: 397-432.
2. ARZT, E., M.P. PAEZ PEREDA, C. PEREZ CASTRO, et al. 1999. Pathophysiological role of the cytokine network in the anterior pituitary gland. Front. Neuroendocrinol. 20: 71-95.
3. BESEDOVSKY, H.O. & A. DEL REY. 1996. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17: 64-102.
4. MCEWEN, B., C. BIRON, K.W. BRUNSON, et al. 1997. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23: 79-133.
5. MCKAY, L.I. & J.A. CIDLOWSKI. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20: 435-459.
6. REFOJO, D., A.C. LIBERMAN, F. HOLSBOER, et al. 2001. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids. Immunol. Cell. Biol. 79: 385-394.
7. COSTAS, M., T. TRAPP, M. PAEZ PEREDA, et al. 1996. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids: TNF-α priming increases glucocorticoid inhibition of TNF-α-induced cytotoxicity/apoptosis. J. Clin. Invest. 98: 1409-1416.
8. CHEN, G. & D.V. GOEDDEL. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
9. HSU, H., H.B. SHU, M.G. PAN, et al. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308.
10. COSTAS, M.A., L. MULLER IGAZ, F. HOLSBOER, et al. 2000. Transrepression of NF-kappaB is not required for glucocorticoid-mediated protection of TNF-alpha-induced apoptosis on fibroblasts. Biochim. Biophys. Acta 1499: 122-129.
11. ZACHARCHUK, C.M., M. MERCEP, P. CHAKRABORTI, et al. 1990. Programmed T lymphocyte death: cell activation and steroid-induced pathways are mutually antagonistic. J. Immunol. 145: 4037-4045.
12. ASHWELL, J.D., F.W.M. LU & M.S. VACCHIO. 2000. Glucocorticoids in T-cell development and function. Ann. Rev. Immunol. 18: 309-345.
13. KRAMMER, P.H. 2000. CD95'S deadly mission in the immune system. Nature 407: 789-795.
14. HAKEM, R., A. HAKEM, G.S. DUNCAN, et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352.
15. KASIBHATLA, S., L. GENESTIER & D.R. GREEN. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274: 987-992.
16. MÜLLER-IGAZ, L., D. REFOJO, M. COSTAS, et al. 2002. CRE-mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. Biochim. Biophys. Acta 1542: 139-148.
17. GLIMCHER, L.H. & K.M. MURPHY. 2000. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14: 1693-1711.
18. REINER, S.L. 2001. Helper T cell differetiation, inside and out. Curr. Opin. Immunol. 13: 351-355.
19. ZHENG, W. & R.A. FLAVELL. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
20. SZABO, S.J., S.T. KIM, G.L. COSTA, et al. 2000. A novel transcription factor, T-bet, direct Th1 lineage commitment. Cell 100: 655-669.
21. GROGAN, J.L. & R.M. LOCKSLEY. 2002. T helper cell differentiation: on again, off again. Curr. Opin. Immunol. 14: 366-372.
22. RAMIREZ, F., D.J. FOWELL, M. PUKLAVEC, et al. 1996. Glucocorticoids promote a Th2 cytokine response by CD4 T cells in vitro. J. Immunol. 156: 2406-2412.
23. GARCIA, M.M. & L.P. KAPCALA. 1995. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. J. Endocrinol. Invest. 18: 450-455.
24. STEFANEANU, L., K. KOVACS, E. HORVATH, et al. 1994. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J. Clin. Endocrinol. Metab. 78: 83-88.
25. LEE, E.J., W.R. DUAN, M. JAKACKA, et al. 2001. Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142: 3756-3763.
26. RAMSDELL, J.S. 1991. Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology 128: 1981-1990.
27. PAEZ PEREDA, M., D. GIACOMINI, D. REFOJO, et al. 2003. Involvement of bone morphogenetic protein Y (BMP-Y) in pituitary prolactinoma pathogenesis through a SMAD/estrogen receptor crosstalk. Proc. Natl. Acad. Sci. USA 100: 1034-1039.